Imaging the expression of glypican-3 in hepatocellular carcinoma by PET.

about

Imaging the expression of glypican-3 in hepatocellular carcinoma by PET.

Item

http://www.wikidata.org/entity/Q50076590

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Imaging the expression of glypican-3 in hepatocellular carcinoma by PET.

@en

Imaging the expression of glypican-3 in hepatocellular carcinoma by PET.

@nl

type

Item

label

Imaging the expression of glypican-3 in hepatocellular carcinoma by PET.

@en

Imaging the expression of glypican-3 in hepatocellular carcinoma by PET.

@nl

prefLabel

Imaging the expression of glypican-3 in hepatocellular carcinoma by PET.

@en

Imaging the expression of glypican-3 in hepatocellular carcinoma by PET.

@nl

P1476

Imaging the expression of glypican-3 in hepatocellular carcinoma by PET.

@en

P2093

Hong-Sheng Li

http://www.w3.org/2001/XMLSchema#string

Hu-Bing Wu

http://www.w3.org/2001/XMLSchema#string

Meng Wang

http://www.w3.org/2001/XMLSchema#string

Quan-Shi Wang

http://www.w3.org/2001/XMLSchema#string

Shun Huang

http://www.w3.org/2001/XMLSchema#string

Wen-Lan Zhou

http://www.w3.org/2001/XMLSchema#string

Yan-Jiang Han

http://www.w3.org/2001/XMLSchema#string

Zhen Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics, 2012

Management of hepatocellular carcinoma: An update

Quantitative analysis and comparison study of [18F]AlF-NOTA-PRGD2, [18F]FPPRGD2 and [68Ga]Ga-NOTA-PRGD2 using a reference tissue model

Hepatocellular carcinoma

Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors.

Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican-3 for liver cancer therapy.

Glypican-3-targeted 89Zr PET imaging of hepatocellular carcinoma.

Diagnostic value of glypican-3 in serum and liver for primary hepatocellular carcinoma

18F-labeled mini-PEG spacered RGD dimer (18F-FPRGD2): synthesis and microPET imaging of alphavbeta3 integrin expression.

Glypican-3: a new target for cancer immunotherapy.

P2888

s00726-017-2517-z

P304

309-320

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00726-017-2517-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29204748

http://www.w3.org/2001/XMLSchema#string